Cigna Group (NYSE:CI) Stock Gets Price Target Cut from Guggenheim

Cigna Group (NYSE:CI – Get Free Report) had its price objective reduced by equities researchers at Guggenheim from $361.00 to $347.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has a “buy” rating on the health services provider’s stock. Guggenheim‘s price target would indicate a potential upside of 15.03% from the stock’s current price.

CI has been the topic of several other reports. Barclays increased their price objective on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. UBS Group restated a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Evercore started coverage on Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $340.00 price objective on shares of Cigna Group in a research note on Friday. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Thursday, August 27th. Fourteen equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $335.70.

View Our Latest Research Report on CI

Cigna Group Price Performance

Shares of CI opened at $301.67 on Friday. The company has a market cap of $79.71 billion, a P/E ratio of 12.48, a PEG ratio of 1.03 and a beta of 0.25. Cigna Group has a fifty-two week low of $255.53 and a fifty-two week high of $318.05. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm’s 50 day moving average price is $285.48 and its 200 day moving average price is $282.05.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating the consensus estimate of $7.52 by $0.46. The company had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the company posted $7.83 EPS. On average, research analysts forecast that Cigna Group will post 30.49 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Everett Neville sold 617 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Several hedge funds and other institutional investors have recently made changes to their positions in CI. Evercore Wealth Management LLC raised its holdings in Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after purchasing an additional 35 shares in the last quarter. Independence Bank of Kentucky boosted its holdings in shares of Cigna Group by 2.6% in the 2nd quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after buying an additional 37 shares in the last quarter. West Family Investments Inc. boosted its holdings in shares of Cigna Group by 4.2% in the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock valued at $253,000 after buying an additional 37 shares in the last quarter. WPG Advisers LLC grew its position in shares of Cigna Group by 24.5% in the 1st quarter. WPG Advisers LLC now owns 203 shares of the health services provider’s stock valued at $54,000 after buying an additional 40 shares during the last quarter. Finally, Maripau Wealth Management LLC grew its position in shares of Cigna Group by 4.0% in the 1st quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider’s stock valued at $287,000 after buying an additional 41 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

  • Positive Sentiment: Q3 adjusted EPS was $7.98, ahead of analyst estimates, and revenue rose about 6% year over year to $73.79 billion, also exceeding consensus. Cigna cited strength in its healthcare businesses and a favorable drug mix. Read More.
  • Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share, reinforcing the view that operating performance is improving. Read More.
  • Positive Sentiment: Cigna also outlined longer-term targets, including 10%–14% adjusted EPS growth and roughly $50 billion in cumulative operating cash flow through 2030. Its $3 billion “Accelerate to One” initiative is intended to improve productivity and modernize operations. Read More.
  • Neutral Sentiment: The planned ACA market exit may simplify Cigna’s business focus, but it also marks a change in its health-insurance footprint. The impact will depend on how the company manages the transition. Read More.
  • Negative Sentiment: GAAP net income was $1.44 billion, down from $1.87 billion a year earlier, and reported EPS declined to $5.47 from $6.98. That contrasts with the stronger adjusted results and may temper the headline earnings beat. Read More.

About Cigna Group

(Get Free Report)

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

Further Reading

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.